Naazish S Bashir
Overview
Explore the profile of Naazish S Bashir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bashir N, Walters T, Griffiths A, Otley A, Critch J, Ungar W
J Can Assoc Gastroenterol
. 2023 Apr;
6(2):73-79.
PMID: 37025514
Objective: Generic preference-based HRQOL assessments used expressly for economic evaluation have not been examined in pediatric Crohn's disease (CD) and ulcerative colitis (UC). The objective was to further assess the...
2.
Bashir N, Walters T, Griffiths A, Otley A, Critch J, Ungar W
Qual Life Res
. 2023 Apr;
32(9):2527-2539.
PMID: 37004628
Purpose: Health utilities are challenging to ascertain in children and have not been studied in pediatric Crohn's disease (CD) and ulcerative colitis (UC). The objective was to assess discriminative validity...
3.
Bashir N, Hughes A, Ungar W
MDM Policy Pract
. 2023 Mar;
8(1):23814683231156433.
PMID: 36860664
Highlights: In an effort to reduce public drug expenditures, Canadian and other jurisdictional drug plans have mandated the use of lower cost, but similarly effective, biosimilars in patients with newly...
4.
Cernat A, Bashir N, Ungar W
J Community Genet
. 2022 Feb;
13(2):155-170.
PMID: 35171498
Direct-to-consumer (DTC) genetic testing exists largely outside of any regulatory schemes, and studies providing a comprehensive overview of the ethical, social, legal, and technological considerations for regulating these types of...
5.
Hayeems R, Luca S, Ungar W, Venkataramanan V, Tsiplova K, Bashir N, et al.
Genet Med
. 2021 Dec;
24(2):430-438.
PMID: 34906486
Purpose: Demonstrating the clinical utility of genetic testing is fundamental to clinical adoption and reimbursement, but standardized definitions and measurement strategies for this construct do not exist. The Clinician-reported Genetic...
6.
Bashir N, Walters T, Griffiths A, Ito S, Ungar W
Expert Rev Pharmacoecon Outcomes Res
. 2021 May;
22(3):445-454.
PMID: 34043481
Objectives: The effect of imputing missing data followed by propensity score analysis on the incremental cost-effectiveness ratio (ICER) in a cost-effectiveness analysis is unknown. The objective was to compare alternative...
7.
Bashir N, Walters T, Griffiths A, Ungar W
Children (Basel)
. 2021 Apr;
8(5).
PMID: 33925356
Health utilities relevant to children are lacking, compromising health funding and policy decisions for children. The Child Health Utility 9D (CHU9D) is a recently developed preference-based health utility instrument designed...
8.
Bashir N, Walters T, Griffiths A, Ito S, Ungar W
Inflamm Bowel Dis
. 2019 Nov;
26(8):1239-1250.
PMID: 31728510
Background: Anti-tumor necrosis factor-α (anti-TNF-α) treatments are increasingly used to treat pediatric Crohn's disease, even without a prior trial of immunomodulators, but the cost-effectiveness of such treatment algorithms has not...
9.
Bashir N, Ungar W
Genome
. 2015 Dec;
58(12):527-40.
PMID: 26623513
The 3-I framework of analyzing the ideas, interests, and institutions around a topic has been used by political scientists to guide public policy development. In Canada, there is a lack...